6/11/2008 8:46:06 AM
JACKSONVILLE, Fla.--(BUSINESS WIRE)--The American Association of Clinical Endocrinologists (AACE) has been closely monitoring the results of two major clinical trials released this week, ADVANCE and ACCORD. The results of the studies highlight controversy concerning the benefits and risks of tight glycemic control. As a result, some patients with type 2 diabetes may be confused about what their treatment goals should be. That is why AACE, the world’s largest association of clinical endocrinologists, is making the following recommendations.
comments powered by